Dianthus Therapeutics Inc (NASDAQ:DNTH)
| 9.49 Delayed Data As of Dec 08 |  -1.10 / -10.39%Today’s Change | 5.14 Today|||52-Week Range 26.24 | +50.16% Year-to-Date |
Latest DNTH News | Press Releases
No recent news for Dianthus Therapeutics Inc.
Today’s Trading
| Previous close | 10.59 |
| Today’s open | 10.12 |
| Day’s range | 9.41 - 10.42 |
| Volume | 917 |
| Average volume (3 months) | 20,357 |
| Market cap | $167.0M |
Data as of 4:00pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | +0.52% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.40 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FATEFate Therapeutics In... | -0.11 | -4.68% |
| MLLCFMolecular Partners A... | 0.00 | 0.00% |
| KZRKezar Life Sciences ... | +0.00 | +0.20% |
| AUTLAutolus Therapeutics... | +0.28 | +6.86% |
Data as of 3:59pm ET, 12/08/2023
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$76.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
